Clinical Trials Directory

Trials / Completed

CompletedNCT02490150

Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill

Administration of Corifollitropin Alfa on Day 5 Versus Day 7 After Last Oral Contraceptive Pill in a GnRH (Gonadotropin-releasing Hormone ) Antagonist Protocol in Donors

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Fundacion Dexeus · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To evaluate if the administration of corifollitropin alfa on day 7 instead of on day 5 after pre-treatment with oral contraceptive pill results in a reduced total rFSH (recombinant follicle stimulating hormone ) consumption in a GnRH antagonist protocol in donors.

Conditions

Interventions

TypeNameDescription
DRUGCorifollitropin alfa

Timeline

Start date
2015-02-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-07-03
Last updated
2017-05-16

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02490150. Inclusion in this directory is not an endorsement.